NeoGenomics, Inc. Contract Liability (Deferred Revenue)
NeoGenomics, Inc. (NEO) had Contract Liability (Deferred Revenue) of $194.00 thousand as of 2026-06-30, per its 10-Q filed 2026-07-28.
Financial Statements › Balance Sheet › Liabilities › Liabilities, Current
us-gaap:ContractWithCustomerLiabilityCurrent · last filed 2026-07-28
- 2026-06-30: Contract with Customer, Liability, Current $194.00K.
- 2026-03-31: Contract with Customer, Liability, Current $561.00K.
- 2025-12-31: Contract with Customer, Liability, Current $851.00K.
- 2025-09-30: Contract with Customer, Liability, Current $1.58M.
| Period end | Contract with Customer, Liability, Current |
|---|---|
| 2026-06-30 | $194.00K 10-Q · filed 2026-07-28 |
| 2026-03-31 | $561.00K 10-Q · filed 2026-04-28 |
| 2025-12-31 | $851.00K 10-Q · filed 2026-07-28 |
| 2025-09-30 | $1.58M 10-Q · filed 2025-10-28 |
| 2025-06-30 | $1.08M 10-Q · filed 2025-07-29 |
| 2025-03-31 | $1.16M 10-Q · filed 2025-04-29 |
| 2024-12-31 | $409.00K 10-K · filed 2026-02-17 |
| 2024-09-30 | $589.00K 10-Q · filed 2024-11-05 |
| 2024-06-30 | $972.00K 10-Q · filed 2024-07-30 |
| 2024-03-31 | $1.14M 10-Q · filed 2024-04-30 |
| 2023-12-31 | $2.13M 10-K · filed 2025-02-18 |
| 2023-09-30 | $3.62M 10-Q · filed 2023-11-06 |
| 2023-06-30 | $5.71M 10-Q · filed 2023-08-08 |
| 2023-03-31 | $6.07M 10-Q · filed 2023-05-09 |
| 2022-12-31 | $7.56M 10-K · filed 2024-02-20 |
| 2022-09-30 | $6.39M 10-Q · filed 2022-11-08 |
| 2022-06-30 | $6.35M 10-Q · filed 2022-08-09 |
| 2022-03-31 | $6.12M 10-Q · filed 2022-05-09 |
| 2021-12-31 | $5.19M 10-K · filed 2023-02-24 |
| 2021-09-30 | $5.28M 10-Q · filed 2021-11-04 |
| 2021-06-30 | $4.50M 10-Q · filed 2021-08-09 |
| 2021-03-31 | $3.99M 10-Q · filed 2021-05-06 |
| 2020-12-31 | $4.03M 10-K · filed 2022-02-25 |
| 2020-09-30 | $3.72M 10-Q · filed 2020-10-29 |
| 2020-06-30 | $3.57M 10-Q · filed 2020-07-31 |
| 2020-03-31 | $2.97M 10-Q · filed 2020-04-29 |
| 2019-12-31 | $1.61M 10-K · filed 2021-02-25 |
| 2019-09-30 | $1.19M 10-Q · filed 2019-11-13 |
| 2019-06-30 | $1.07M 10-Q · filed 2019-08-07 |
| 2019-03-31 | $1.02M 10-Q · filed 2019-05-08 |
| 2018-12-31 | $927.00K 10-K · filed 2020-02-28 |
| 2018-09-30 | $1.26M 10-Q · filed 2018-11-06 |
| 2018-06-30 | $2.15M 10-Q · filed 2018-08-06 |
| 2018-03-31 | $2.19M 10-Q · filed 2018-05-08 |
| 2017-12-31 | $1.41M 10-K · filed 2019-02-26 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| 20/20 Biolabs, Inc. (AIDX) | United States | $0.005B |